By Professor David Thomas

Journal articles

Newnham GM; Thomas DM; McLachlan SA; Wright G; Conron M, 2008, 'Molecular Profiling of Non-Small Cell Lung Cancer: Of What Value in Clinical Practice?', Heart Lung and Circulation, 17, pp. 451 - 462, http://dx.doi.org/10.1016/j.hlc.2007.11.144

Gutierrez GM; Kong E; Sabbagh Y; Brown NE; Lee JS; Demay MB; Thomas DM; Hinds PW, 2008, 'Impaired bone development and increased mesenchymal progenitor cells in calvaria of RB1^-/- mice', Proceedings of the National Academy of Sciences of the United States of America, 105, pp. 18402 - 18407, http://dx.doi.org/10.1073/pnas.0805925105

Alvaro F; Young A; Goldstein D; Thomas D; McJannett M; Dillon R, 2008, 'Clinical oncological society of Australia: Adolescent and young adult cancer forum', Cancer Forum, 32, pp. 116 - 119

Thomas D; Chawla SP; Skubitz K; Staddon AP; Henshaw R; Blay JY; Smith J; Ye Z; Roudier M; Jun S, 2008, 'Denosumab treatment of giant cell tumor of bone: Interim analysis of an open-label phase II study', Journal of Clinical Oncology, 26, pp. 10500 - 10500, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.10500

Thomas DM; Francescutti-Verbeem DM; Kuhn DM, 2008, 'The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity', JOURNAL OF NEUROCHEMISTRY, 105, pp. 605 - 616, http://dx.doi.org/10.1111/j.1471-4159.2007.05155.x

Bleyer A; Barr R; Hayes-Lattin B; Thomas D; Ellis C; Anderson B, 2008, 'The distinctive biology of cancer in adolescents and young adults', Nature Reviews Cancer, 8, pp. 288 - 298, http://dx.doi.org/10.1038/nrc2349

Khamly KK; Hicks RJ; McArthur GA; Thomas DM, 2008, 'The promise of PET in clinical management and as a sensitive test for drug cytotoxicity in sarcomas', Expert Review of Molecular Diagnostics, 8, pp. 105 - 119, http://dx.doi.org/10.1586/14737159.8.1.105

Clark JCM; Thomas DM; Choong PFM; Dass CR, 2007, 'RECK - A newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer', Cancer and Metastasis Reviews, 26, pp. 675 - 683, http://dx.doi.org/10.1007/s10555-007-9093-8

Fon A; Mileshkin L; Slavin J; Twomey H; James P; Thomas DM, 2007, 'Synchronous diagnosis of Hodgkin lymphoma and osteosarcoma [1]', Internal Medicine Journal, 37, pp. 731 - 732, http://dx.doi.org/10.1111/j.1445-5994.2007.01465.x

Thomas DM, 2007, 'Adolescents and young adults with cancer: The challenge', Palliative and Supportive Care, 5, pp. 173 - 174, http://dx.doi.org/10.1017/S1478951507070253

Kansara M; Thomas DM, 2007, 'Molecular pathogenesis of osteosarcoma', DNA and Cell Biology, 26, pp. 1 - 18, http://dx.doi.org/10.1089/dna.2006.0505

Krypuy M; Newnham GM; Thomas DM; Conron M; Dobrovic A, 2006, 'High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer', BMC Cancer, 6, http://dx.doi.org/10.1186/1471-2407-6-295

Chaffer CL; Thomas DM; Thompson EW; Williams ED, 2006, 'PPARγ-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma', BMC Cancer, 6, http://dx.doi.org/10.1186/1471-2407-6-53

Tan JZY; Schlicht SM; Powell GJ; Thomas D; Slavin JL; Smith PJ; Choong PFM, 2006, 'Multidisciplinary approach to diagnosis and management of osteosarcoma - A review of the St Vincent's Hospital experience', International Seminars in Surgical Oncology, 3, http://dx.doi.org/10.1186/1477-7800-3-38

Thomas D; Kansara M, 2006, 'Epigenetic modifications in osteogenic differentiation and transformation', Journal of Cellular Biochemistry, 98, pp. 757 - 769, http://dx.doi.org/10.1002/jcb.20850

Lee JS; Thomas DM; Gutierrez G; Carty SA; Yanagawa SI; Hinds PW, 2006, 'HES1 cooperates with pRb to activate RUNX2-dependent transcription', Journal of Bone and Mineral Research, 21, pp. 921 - 933, http://dx.doi.org/10.1359/jbmr.060303

Thomas DM; Seymour JF; O'Brien T; Sawyer SM; Ashley DM, 2006, 'Adolescent and young adult cancer: A revolution in evolution?', Internal Medicine Journal, 36, pp. 302 - 307, http://dx.doi.org/10.1111/j.1445-5994.2006.01062.x

Amukotuwa SA; Choong PFM; Smith PJ; Powell GJ; Thomas D; Schlicht SM, 2006, 'Femoral mesenchymal chondrosarcoma with secondary aneurysmal bone cysts mimicking a small-cell osteosarcoma', Skeletal Radiology, 35, pp. 311 - 318, http://dx.doi.org/10.1007/s00256-005-0044-6

Slavin JL; Thomas D, 2006, 'Gene expression profiling of sarcomas', Pathology, 38, pp. 101 - 102, http://dx.doi.org/10.1080/00313020600595854

Cullinane C; Dorow DS; Kansara M; Conus N; Binns D; Hicks RJ; Ashman LK; McArthur GA; Thomas DM, 2005, 'An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development', Cancer Research, 65, pp. 9633 - 9636, http://dx.doi.org/10.1158/0008-5472.CAN-05-2285

Dudley AC; Thomas D; Best J; Jenkins A, 2005, 'A VEGF/JAK2/STAT5 axis may partially mediate endothelial cell tolerance to hypoxia', Biochemical Journal, 390, pp. 427 - 436, http://dx.doi.org/10.1042/BJ20050351

Thomas DM; Kuhn DM, 2005, 'Cyclooxygenase-2 is an obligatory factor in methamphetamine-induced neurotoxicity', JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 313, pp. 870 - 876, http://dx.doi.org/10.1124/jpet.104.080242

Morgan T; Atkins GJ; Trivett MK; Johnson SA; Kansara M; Schlicht SL; Slavin JL; Simmons P; Dickinson I; Powell G; Choong PFM; Holloway AJ; Thomas DM, 2005, 'Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor κB', American Journal of Pathology, 167, pp. 117 - 128, http://dx.doi.org/10.1016/S0002-9440(10)62959-8

Thomas DM; Johnson SA; Sims NA; Trivett MK; Slavin JL; Rubin BP; Waring P; McArthur GA; Walkley CR; Holloway AJ; Diyagama D; Grim JE; Clurman BE; Bowtell DDL; Lee JS; Gutierrez GM; Piscopo DM; Carty SA; Hinds PW, 2004, 'Terminal osteoblast differentiation, mediated by runx2 and p27 ^KIP1, is disrupted in osteosarcoma', Journal of Cell Biology, 167, pp. 925 - 934, http://dx.doi.org/10.1083/jcb.200409187

Thomas DM; Fleming NI; Holloway AJ; Bowtell DDL, 2004, 'Molecular medicine: A clinician's primer on microarrays', Internal Medicine Journal, 34, pp. 565 - 569, http://dx.doi.org/10.1111/j.1445-5994.2004.00680.x

Dudley AC; Thomas D; Best J; Jenkins A, 2004, 'The STATs in cell stress-type responses', Cell Communication and Signaling, 2, http://dx.doi.org/10.1186/1478-811X-2-8

Dudley A; Gilbert RE; Thomas D; Cox A; Price JT; Best J; Jenkins A, 2003, 'STI-571 inhibits in vitro angiogenesis', Biochemical and Biophysical Research Communications, 310, pp. 135 - 142, http://dx.doi.org/10.1016/j.bbrc.2003.08.129

Chin SL; Johnson SA; Quinn J; Mirosavljevic D; Price JT; Dudley AC; Thomas DM, 2003, 'A role for αV integrin subunit in TGF-β-stimulated osteoclastogenesis', Biochemical and Biophysical Research Communications, 307, pp. 1051 - 1058, http://dx.doi.org/10.1016/S0006-291X(03)01294-4

Thomas DM; Yang HS; Alexander K; Hinds PW, 2003, 'Role of the retinoblastoma protein in differentiation and senescence', Cancer Biology and Therapy, 2, pp. 124 - 130, http://dx.doi.org/10.4161/cbt.2.2.235

Dudley A; McKinstry W; Thomas D; Best J; Jenkins A, 2003, 'Removal of endotoxin by reverse phase HPLC abolishes anti-endothelial cell activity of bacterially expressed plasminogen kringle 5', BioTechniques, 35, pp. 724 - 732, http://dx.doi.org/10.2144/03354st02

Cook N; Thomas DM, 2002, 'Retrospective survey of unselected hospital patients with and without cancer comparing outcomes following venous thromboembolism', Internal Medicine Journal, 32, pp. 437 - 444, http://dx.doi.org/10.1046/j.1445-5994.2002.00249.x

Rosenthal MA; Thomas D; Davis I; Toner G; Noordin N; Zalcberg J, 2001, 'Pilot study of oral eniluracil/5-FU in the palliation of hormone-refractory prostate cancer', Prostate Journal, 3, pp. 30 - 35, http://dx.doi.org/10.1046/j.1525-1411.2001.003001030.x

Thomas DM; Carty SA; Piscopo DM; Lee JS; Wang WF; Forrester WC; Hinds PW, 2001, 'The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation', Molecular Cell, 8, pp. 303 - 316, http://dx.doi.org/10.1016/S1097-2765(01)00327-6

Puche RC; Thomas DM; Udagawa N; Hards DK; Quinn JMW; Moseley JM; Findlay DM; Best JD, 1999, 'Letters to the editor (multiple letters).', Bone, 25

Ebeling PR; Thomas DM; Erbas B; Hopper JL; Szer J; Grigg AP, 1999, 'Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation', Journal of Bone and Mineral Research, 14, pp. 342 - 350, http://dx.doi.org/10.1359/jbmr.1999.14.3.342

Thomas DM; Mitchell PLR; Berlangieri SU; Tochon-Danguy H; Knight S; Clarke CP; Scott AM, 1998, 'Correction: Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer (Medical Journal of Australia (1998) 169 (227))', Medical Journal of Australia, 169, pp. 344

Thomas DM; Mitchell PLR; Berlangieri SU; Tochon-Danguy H; Knight S; Clarke CP; Scott AM, 1998, 'Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer (vol 169, pg 227, 1998)', MEDICAL JOURNAL OF AUSTRALIA, 169, pp. 344 - 344, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000076023200028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thomas DM; Udagawa N; Hards DK; Quinn JMW; Moseley JM; Findlay DM; Best JD, 1998, 'Insulin receptor expression in primary and cultured osteoclast-like cells', Bone, 23, pp. 181 - 186, http://dx.doi.org/10.1016/S8756-3282(98)00095-7

Thomas DM; Zalcberg JR, 1998, '5-Fluorouracil: A pharmacological paradigm in the use of cytotoxics', Clinical and Experimental Pharmacology and Physiology, 25, pp. 887 - 895, http://dx.doi.org/10.1111/j.1440-1681.1998.tb02339.x

Thomas DM; Mitchell PLR; Berlangieri SU; Tochon-Danguy H; Knight S; Clarke CP; Scott AM, 1998, 'Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer [1]', Medical Journal of Australia, 169, pp. 227, http://dx.doi.org/10.5694/j.1326-5377.1998.tb140229.x

Thomas DM; Seymour JF; Szer J; Grigg AP; Basser RL; Green MD; Fox RM; Thomas DM, 1998, 'Progress in management of acute myeloid leukaemia (AML) in Australia since 1980: A single institution retrospective study', Australian and New Zealand Journal of Medicine, 28, pp. 190 - 196, http://dx.doi.org/10.1111/j.1445-5994.1998.tb02968.x

Thomas DM; Ng KW; Best JD, 1997, 'Insulin and bone: A clinical and scientific review', Endocrinology and Metabolism, Supplement, 4, pp. 5 - 17

Thomas DM; Seymour JF; Griffiths JD; Szer J; Grigg AP, 1997, 'Prolonged disease-free survival with specific re-induction therapy in acute myeloid leukaemia relapsing following bone marrow transplantation', Australian and New Zealand Journal of Medicine, 27, pp. 712 - 713, http://dx.doi.org/10.1111/j.1445-5994.1997.tb01009.x

Thomas DM; Maher F; Rogers SD; Best JD, 1996, 'Expression and regulation by insulin of Glut 3 in UMR 106-01, a clonal rat osteosarcoma cell line', Biochemical and Biophysical Research Communications, 218, pp. 789 - 793, http://dx.doi.org/10.1006/bbrc.1996.0140

Thomas DM; Rogers SD; Ng KW; Best JD, 1996, 'Dexamethasone modulates insulin receptor expression and subcellular distribution of the glucose transporter GLUT 1 in UMR 106-01, a clonal osteogenic sarcoma cell line', Journal of Molecular Endocrinology, 17, pp. 7 - 17, http://dx.doi.org/10.1677/jme.0.0170007

Thomas DM; Hards DK; Rogers SD; Ng KW; Best JD, 1996, 'Insulin receptor expression in bone', Journal of Bone and Mineral Research, 11, pp. 1312 - 1320, http://dx.doi.org/10.1002/jbmr.5650110916

Thomas DM; Rogers SD; Sleeman MW; Pasquini GM; Bringhurst FR; Ng KW; Zajac JD; Best JD, 1995, 'Modulation of glucose transport by parathyroid hormone and insulin in UMR 106-01, a clonal rat osteogenic sarcoma cell line', Journal of Molecular Endocrinology, 14, pp. 263 - 275, http://dx.doi.org/10.1677/jme.0.0140263

Conference Papers

Thavaneswaran S; Sebastian L; Finlayson S; Desai J; O'Byrne K; Harrup R; Ballinger ML; Lin F; Grady JP; Kansara M; Simes J; Leland SM; Jansen VM; Cavers AC; Thomas DM, 2021, 'CRESTONE: Clinical Study of REsponse to Seribantumab in Tumours with NEuregulin-1 (NRG1) Fusions: A phase 2 study of the anti-HER3 monoclonal antibody for advanced or metastatic solid tumours (MoST CRESTONE in Australia)', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 206 - 206, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500346&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Scott CL; Lim R; Kee D; Georgiou C; Caldwell R; Papadopoulos L; Krasovitsky MS; Tay R; Bourne A; Vandenberg C; Dall G; Shield-Artin K; Carmagnac A; Ratnayak G; Tram J; Zhou W; Bedo J; Penington J; Zhu L; Vissers J; Thomas D; Grimmond S; Wakefield M; Papenfuss T; Barke H; Goldstein D, 2021, 'Delivering personalized care and research for rare cancers in the increasingly genomic world?', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500102&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bartley N; Best MC; Biesecker BB; Fisher A; Goldstein D; Meiser B; Thomas DM; Ballinger ML; Butow P, 2021, 'Effectively communicating comprehensive tumour genomic profiling results: Mitigating uncertainty for advanced cancer patients', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 180 - 180, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000717281500295&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page